longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Junshi Biosciences

688180

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -75.28, below the reasonable range, cheaper than 98.34% of the time in the past 3 years, and the industry ranks 73/85, the industry Median 11.59.

-75.28xP/E
¥32.32Stock price
¥-0.43Earnings per share
-75.28xP/E
Stock price¥32.32Earnings per share¥-0.43

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-19.99x
Typical range
-41.53x–-14.30x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.59x
03978117156

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.59x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688180SHJunshi Biosciences
-75.28x92.53%¥33.18B
603392SHWantai Biological
-83.03x22.02%¥31.76B
300122SZZHIFEI-BIOL
-1.98x91.71%¥29.52B
688192SHDizal Pharmaceutical
-43.43x255.85%¥25.93B
300676SZBGI Genomics
-26.84x118.23%¥15.44B
688520SHSinocelltech
-16.99x171.21%¥15.24B
688765SHHEALTHGEN BIOTECH
-92.11x--¥12.73B
688062SHMabwell
-12.03x37.63%¥11.30B
688319SHOlymvax Biopharmaceuticals
-456.33x227.87%¥10.86B
688382SHInventisBio
-32.19x5.45%¥10.77B
300204SZStaidson BioPharm
-117.01x--¥10.52B
688105SHVazyme
-1,188.21x770.82%¥10.43B
688806SHTrinomab Pharmaceutical
-19.00x--¥9.70B
688759SHBeBetter Med
-52.96x12.50%¥9.40B
688443SHGenrix Bio
-14.54x32.19%¥8.18B
002030SZDAJY
-10.73x--¥7.33B
300294SZBOYA BIOLOGY
-114.87x281.82%¥7.06B
688177SHBIO-THERA
-14.97x2.47%¥6.87B
688488SHAidea Pharma
-1,120.79x--¥6.49B
688276SHBCHT
-25.63x66.67%¥6.18B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.